RA Capital Management, L.P. 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:45 pm Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | RA Capital Management, L.P. | 19,549,271 9.900% | 6,289,536 (+47.43%) | Filing |
| 2025-12-18 6:07 pm Purchase | 2025-12-11 | 13G | OVID THERAPEUTICS INC OVID | RA Capital Management, L.P. | 13,259,735 9.900% | 13,259,735 (New Position) | Filing |